Related Experiment Video
Updated: Mar 7, 2026

05:46
A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
4.2K
Bioengineered three-dimensional diseased intervertebral disc model revealed inflammatory crosstalk.
Akshay Srivastava1, Isma Liza Mohd Isa1, Peadar Rooney1
1CÚRAM, Centre for Research in Medical Devices, National University of Ireland Galway, Ireland.
Biomaterials
|February 8, 2017
Summary
Researchers developed a novel 3D intervertebral disc (IVD) model to study degeneration. This model revealed the role of suppressor of cytokine signaling (SOCS) proteins in combating inflammation in degenerated IVD tissues.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Tissue Engineering
Background:
- Understanding intervertebral disc degeneration (IVDD) pathophysiology is limited by the lack of appropriate disease models.
- This knowledge gap hinders the identification of therapeutic targets for IVDD treatment.
Purpose of the Study:
- To develop a versatile three-dimensional (3D) intervertebral disc (IVD) model.
- To investigate the response of nucleus pulposus (NP) and annulus fibrosus (AF) cells to inflammatory stimulation (IL-1β).
Main Methods:
- Engineered a cell shape-regulated IVD model by modulating collagen hydrogel crosslinking.
- Studied molecular changes at the genetic level in response to inflammation.
- Analyzed extracellular matrix production and inflammatory pathways.
Main Results:
- Identified the role of suppressor of cytokine signaling (SOCS) proteins in mitigating pro-inflammatory cytokine effects in degenerated NP tissue.
- Gained insights into genetic modulation of extracellular matrix components and inflammatory pathways.
- Provided understanding of glycan expression in diseased IVD.
Conclusions:
- The developed 3D IVD model is a versatile tool for studying IVDD.
- The SOCS family plays a crucial role in protecting against inflammatory damage in degenerated IVD.
- The model aids in understanding molecular mechanisms and glycan expression in IVDD.

